Antonio
Garreta Rufas
Ingelheim am Rheim
Germany
Back
Wcn26 Post edited Speaker Card
29 March 2026
Time
Session
3:50 p.m.
4:50 p.m.
Industry Digest: Insights into Latest Innovations from Scientific Leads
Advancing the Next Wave of Therapies in Chronic Kidney Disease
Dustin
Little
Speaker
dustin.little@astrazeneca.com
United States
Effects of Finerenone on Biomarkers: Mechanistic Insights From Proteomic Analyses in Clinical Trials
Mario
Berger
Speaker
mario.berger@bayer.com
Germany
Future Directions in CRM Care: Advancing Research and Therapeutic Innovation
Antonio
Garreta Rufas
Speaker
antonio.garreta_rufas@boehringer-ingelheim.com
Germany
Innovative Strategies for Clinical Trial Design in IgAN
Jeffrey
Hafkin
Speaker
jeffrey.hafkin@otsuka-us.com
United States
Improving Outcomes in Complement-mediated Kidney Diseases
Marianne Silkjær Nielsen
Speaker
Msn@compcure.org
Switzerland
Advancing Mechanistic Trials through Industry–Academia Collaboration: Insights from the REMODEL Trial
Manuel
Mayrdorfer
Speaker
mumf@novonordisk.com
Denmark
Why? When? How? How to Maximize Patient Outcomes From the Start of Dialysis
Peter
Rutherford
Speaker
peter.rutherford@vantive.com
Switzerland
301 - 302